Publications by authors named "Panagiotis Repousis"

Claim this Profile
A
Aggressive T-Cell Large Granular Lymphocyte Leukemia With the Unusual Double-Negative CD4-/CD8-/TCRαβ+ Phenotype; Report of Two Cases and Review of the Literature.
Angeliki Kotsiafti, Nikolaos J Tsagarakis, Chrissa M Vadikolia, Dimitrios Maltezas, Christina Karela, Panagiotis Repousis

Int J Lab Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Floating Carotid Thrombus in a Patient With Essential Thrombocytemia due to Calreticulin Mutation.
Klearchos Psychogios, Odysseas Kargiotis, Apostolos Safouris, Panagiotis Repousis, Georgios Tsivgoulis

Stroke· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pomalidomide Plus Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World "POWERFUL" Study.
Evangelos Terpos, Panagiotis Repousis, Chrysavgi Lalayanni, Evdoxia Hatjiharissi, Theodora Assimakopoulou

J Clin Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of 5-azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes.
Panagiotis T Diamantopoulos, Argiris Symeonidis, Vasiliki Pappa, Ioannis Kotsianidis, Athanasios Galanopoulos, Panagiotis Repousis

Br J Haematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating multi-disciplinary discussion in clinical practice.
Ilias C Papanikolaou, Andreas Afthinos, Alexandra Papoudou-Bai, Panagiotis Repousis

Adv Respir Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry.
Panagiotis T Diamantopoulos, Vasiliki Pappa, Argiris Symeonidis, Ioannis Kotsianidis, Athanasios Galanopoulos, Panagiotis Repousis

Clin Lymphoma Myeloma Leuk· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of 5-Azacytidine in older patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia: A retrospective analysis of the Hellenic (Greek) MDS Study Group.
Sotirios G Papageorgiou, Christos K Kontos, Ioannis Kotsianidis, Paraskevi Karousi, Argyris Symeonidis, Panagiotis Repousis

J Geriatr Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A revised international prognostic score system for Waldenström's macroglobulinemia.
Efstathios Kastritis, Pierre Morel, Alain Duhamel, Maria Gavriatopoulou, Marie Christine Kyrtsonis, Panagiotis Repousis

Leukemia· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5-azacytidine: Results from the Hellenic 5-azacytidine registry.
Panagiotis Diamantopoulos, Dafni Koumbi, Ioannis Kotsianidis, Vasiliki Pappa, Argiris Symeonidis, Panagiotis Repousis

Cancer Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis.
Panagiotis Tsirigotis, Theodoros Vassilakopoulos, Ioannis Batsis, Zoi Bousiou, Konstantinos Gkirkas, Panagiotis Repousis

Hematol Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group.
Sotirios G Papageorgiou, Christos K Kontos, Ioannis Kotsianidis, Diamantina Vasilatou, Argyris Symeonidis, Panagiotis Repousis

Hematol Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience.
Maria K Angelopoulou, Theodoros P Vassilakopoulos, Ioannis Batsis, Ioanna Sakellari, Konstantinos Gkirkas, Panagiotis Repousis

Hematol Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of the detection of paroxysmal nocturnal hemoglobinuria clones in patients with multiple myeloma undergoing autologous stem cell transplantation.
Vasileios Chatziantoniou, Stavroula Alexia, Kostas Konstantopoulos, Panagiotis Repousis, Aikaterini Megalakaki

Hematol Oncol Stem Cell Ther· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience.
Eirini Katodritou, Evangelos Terpos, Efstathios Kastritis, Sossana Delimpasis, Argiris S Symeonidis, Panagiotis Repousis

Ann Hematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy.
Efstathios Kastritis, Marie-Christine Kyrtsonis, Pierre Morel, Maria Gavriatopoulou, Evdoxia Hatjiharissi, Panagiotis Repousis

Haematologica· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents.
Flora Zagouri, Efstathios Kastritis, Argiris S Symeonidis, Nikolaos Giannakoulas, Eirini Katodritou, Panagiotis Repousis

Eur J Haematol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting with extramedullary relapse.
Xenofon Papanikolaou, Panagiotis Repousis, Tatiana Tzenou, Dimitris Maltezas, Maria Kotsopoulou

Leuk Lymphoma· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents.
Dimitrios Maltezas, Meletios A Dimopoulos, Irene Katodritou, Panagiotis Repousis, Anastasia Pouli

Hematol Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple myeloma in octogenarians: clinical features and outcome in the novel agent era.
Meletios A Dimopoulos, Efstathios Kastritis, Sossana Delimpasi, Eirini Katodritou, Eleftheria Hatzimichael, Panagiotis Repousis

Eur J Haematol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Hodgkin's lymphoma patients with relapse or progression following autologous hematopoietic cell transplantation.
Panayotis Kaloyannidis, Georgia Voutiadou, Ioannis Baltadakis, Panagiotis Tsirigotis, Alexandros Spyridonidis, Panagiotis Repousis

Biol Blood Marrow Transplant· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center.
Ourania Nicolatou-Galitis, Erofili Papadopoulou, Triantafyllia Sarri, Polyxeni Boziari, Aikaterini Karayianni, Panagiotis Repousis

Oral Surg Oral Med Oral Pathol Oral Radiol Endod· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High levels of serum angiogenic growth factors in patients with AL amyloidosis: comparisons with normal individuals and multiple myeloma patients.
Efstathios Kastritis, Maria Roussou, Michalis Michael, Maria Gavriatopoulou, Evridiki Michalis, Panagiotis Repousis

Br J Haematol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematologic toxicity in patients treated with sunitinib for advanced thyroid cancer.
Anastasios Gkountouvas, Ifigeneia Kostoglou-Athanassiou, Eirini Veniou, Panagiotis Repousis, Nikolaos Ziras

Thyroid· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis